Hemodialysis Complications of Hydroxocobalamin: A Case Report by Mark Sutter et al.
TOXICOLOGY OBSERVATION
Hemodialysis Complications of Hydroxocobalamin:
A Case Report
Mark Sutter & Nadia Tereshchenko & Rokhsara Rafii &
G. Patrick Daubert
Published online: 30 March 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Hydroxocobalamin is a new antidote approved
by the FDA for the treatment of cyanide poisoning. Our
report describes a patient with cyanide poisoning who
survived after treatment with hydroxocobalamin and com-
plications we encountered with hemodialysis. A 34-year-
old female presented to the emergency department after a
syncopal event and seizures. Her systolic blood pressure
was 75 mmHg, her QRS complex progressively widened,
and pulses were lost. She was intubated and resuscitated
with fluids, sodium bicarbonate for her QRS widening and
vasopressors. Venous blood gas demonstrated a pH of 6.36
with an O2 saturation of 99%. Due to the acidemia with a
normal pulse oximetry, simultaneous venous and arterial
blood gases were obtained. Venous gas demonstrated a pH
of 6.80 with a PO2 of 222 mmHg, an O2 saturation of 99%.
The arterial blood gas showed a pH of 6.82, a PO2 518 mmHg,
an O2 saturation of 100%. Cyanide was suspected and
hydroxocobalamin and sodium thiosulfate were given. Within
40 min of hydroxocobalamin administration, vasopressors
were discontinued. Initially, nephrology attempted dialysis for
metabolic acidosis; however, the dialysis machine repeatedly
shut down due to a “blood leak”. This was an unforeseen
effect attributed to hydroxocobalamin. Cyanide level, drawn
20 min after the antidote was completed, was elevated at
22 mcg/dL. Her urinary thiocyanate level could not be
analyzed due to an “interfering substance”. Hydroxocobala-
min is an effective antidote. However, clinicians must be
aware of its effects on hemodialysis machines which could
delay the initiation of this important treatment modality in the
severely acidemic patient.
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Introduction
The lethal effects of cyanide poisoning have been well
described [1]. Cyanide is a potent cellular toxin that
interferes with aerobic metabolism by blocking cytochrome
a-a3 of the electron transport system. This blockade
eventually leads to a significant increase in anaerobic
metabolism and a profound lactic acidosis. Death from
cyanide toxicity is the result of multi-system organ failure
that stems from the body’s inability to utilize oxygen [2].
On December 15, 2006, a new antidote for the treatment of
cyanide poisoning, hydroxocobalamin, (Cyanokit™, Dey
Laboratories, Napa, CA, USA) was approved by the FDA
[3]. In contrast to previously utilized antidotes, hydroxoco-
balamin binds cyanide without decreasing the oxygen
carrying capacity of hemoglobin. Hydroxocobalamin binds
to cyanide to form cyanocobalamin which can then be
excreted in the urine. Additionally, sodium thiosulfate can
also be administered to provide another mechanism to
enhance cyanide excretion [4].
The side effects of hydroxocobalamin are minimal making
it advantageous to previous antidotes. Hydroxocobalamin is
known to cause an orange/red discoloration of the blood,
urine, and secretions. This discoloration of the bodily fluids
has been shown to interfere with several chemistry method-
ologies. This interference has been established to cause
statically significant alterations in aspartate aminotransferase,
bilirubin, creatinine, magnesium, and iron [5–7]. Other
colorimetric tests have also been influenced by both
hydroxocobalamin and the resulting cyanocobalamin. This
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can lead to interferences and calculation errors by co-oximeter
measurements of carboxyhemoglobin, methemoglobin, oxy-
hemoglobin, and hemoglobin [8, 9]. An additional side effect
of hydroxocobalamin is hypertension; however, this is often
a desired effect in the critically ill patient [5].
A classical presentation of cyanide often includes the
sudden onset of syncope, seizures, and eventual cardiovascu-
lar collapse [1]. We present a case consistent with cyanide
poisoning who survived neurologically intact, after treatment
with hydroxocobalamin and sodium thiosulfate. We also
describe some challenges encountered after hydroxocobalamin
administration.
Case Report
A 34-year-old female with bipolar disorder presented after
her roommate witnessed a syncopal event followed by
tonic-clonic seizure activity. She arrived in the emergency
department 11 min after her roommate called 911. Her
initial systolic blood pressure was 75 mmHg, and the
cardiac monitor showed a narrow complex rhythm that
began to widen just before carotid pulses were lost. The
patient was intubated, intravenous fluids started and two
ampoules of sodium bicarbonate were rapidly administered
due to the QRS widening on the monitor. Cardiopulmonary
resuscitation was begun and pulses returned following the
administration of epinephrine and atropine. A critical lab
value demonstrated a venous blood pH of 6.36. Two
additional ampoules of sodium bicarbonate were pushed,
and repeat venous blood gas exhibited a pH of 6.41.
Norepinephrine was initiated and simultaneous placement
of both an internal jugular venous line and a radial arterial
line occurred with both returning bright red blood. Because
of the findings of bright red venous blood in this severely
acidemic patient with a pulse oximetry of 99–100%, we
obtained simultaneous arterial and venous blood gases. The
internal jugular venous gas demonstrated a pH of 6.80 with
a PO2 of 222 mmHg, an O2 saturation of 99%, a PCO2 of
57 mmHg and bicarcarbonate of 9 mEq/L. The radial artery
blood gas showed a pH of 6.82, a PO2 518 mmHg, an O2
saturation of 100%, a PCO2 of 55 mmHg, and bicarbonate
of 9 mEq/L. Additionally, a carboxyhemoglobin level was
0.4% and methemoglobin was 0.6%. Cyanide toxicity was
suspected given the profound metabolic acidosis and
limited systemic oxygen extraction. The oxygen extraction
from arterial to venous side was markedly decreased as the
calculated oxygen extraction was only 6%. The patient
received 5 g of hydroxocobalamin over 15 min followed by
12.5 g of sodium thiosulfate infused over 30 min.
Within 15 min of the start of the hydroxocobalamin
infusion, blood pressure had increased, and norepinephrine
was weaned. Forty minutes after the start of the hydrox-
ocobalamin infusion, norepinephrine was discontinued and
the patient’s systolic blood pressure was 115 mmHg.
Twenty minutes later, a repeat arterial blood gas demon-
strated a pH of 7.32, a PO2 of 445 mmHg, an O2 saturation
of 100%, a PCO2 of 41 mmHg, and a bicarbonate of
23 mEq/L. Initial laboratories subsequently returned with a
potassium of 4.1 mEq/L and a dramatically elevated lactic
acid level of 32.4 mEq/L (normal 0.2–2.2 mEq/L).
During the initial resuscitation, the nephrology service
attempted to dialyze the patient for overwhelming metabolic
acidosis. However, the hemodialysis machine (Fresenius
2008 K) repeatedly alarmed and shut down due to a “blood
leak”. It took several hours to turn off the internal alarms to
allow for hemodialysis to begin. Fortunately, by this time the
acidosis had corrected and hemodialysis was no longer
needed. Ethylene glycol and methanol levels returned as
undetectable. The patient was extubated the next day and was
neurologically intact. On hospital day4, whole blood cyanide
levels, which were drawn 20 min after the antidote was
completely infused in the emergency department, returned
elevated at 22 μg/dL (normal 0–20 μg/dL, ARUP Laborato-
ries, Salt Lake City, UT, USA). Repeat cyanide levels from
hospital day3 were undetectable. Unfortunately, blood sam-
ples obtained prior to antidote administration were utilized for
immediate testing and a sample was not available for send-out
analysis. Urinary thiocyanate levels were unable to be










Left:  Normal light transparency.          Right:  Interfering substance decreases transparency and shuts off dialysis machine
Fig. 1 Hemodialysis blood leak
alarm
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The patient denied a suicidal ingestion of cyanide or
potential exposure to any other cellular toxins, such as
hydrogen sulfide, that would explain her clinical condition
and rapid response to the therapy provided. However, there
were several concerning factors in the patients social
situation that prompted law enforcement involvement. An
investigation for attempted homicide is on-going.
Discussion
This case demonstrates the successful treatment of cyanide
poisoning by combining supportive care with hydroxocobala-
min and sodium thiosulfate. Our patient presented with
syncope, seizures, and an overwhelming lactic acidosis. The
finding of the arteriolization of the venous blood gas with
minimal oxygen extraction immediately led us to suspect
cyanide toxicity. The patient’s rapid clinical response to our
therapy including hydroxocobalamin and sodium thiosulfate,
in combination with her elevated blood cyanide level
convinced us that our diagnosis was correct. Additional
etiologies were considered; however, urine toxicology screens
were negative for drugs of abuse, adrenal and thyroid function
testing was normal, blood cultures did not isolate any
organisms, and other etiologies known to elevate cyanide
levels such as cigarette smoking and nitroprusside were absent.
We did experience unexpected challenges following
hydroxocobalamin administration. The major difficulty we
encountered was the inability to perform hemodialysis.
Internal alarms repeatedly shut down the hemodialysis
machine due to detection of a “blood leak”. Normally, in the
circuit of a hemodialysis machine, blood passes on one side of
a semi-permeable membrane, and red blood cells do not cross
into the dialysate. As a safety precaution, all hemodialysis
machines have built-in infrared or photodetector sensors that
alarm and stop the machine if red blood cells penetrate into the
dialysate. This photodetector is at the bottom of the dialysate
column with the light source on the top shooting light towards
the photodetector. Substances that deflect or scatter light will
be detected because transparency at the base of the column is
lost triggering the dialysis machine to stop (Fig. 1). Com-
monly, the substance that interferes by deflecting light is red
blood cells; therefore, this alarm is called a “blood leak”
[10]. With hydroxocobalamin administration, bodily fluids
become discolored. The hemodialysis machine falsely inter-
prets this discoloration as a “blood leak” and shuts down
machine operation. It took several hours to disable the internal
alarms to perform hemodialysis. Fortunately, hemodialysis
was probably unnecessary for our patient because her
metabolic acidosis resolved. However, if hydroxocobalamin
were given empirically to a patient with an overwhelming
acidosis of an unknown etiology (i.e., toxic alcohols, sepsis, or
metformin-associated lactic acidosis), the ability to perform
hemodialysis might be delayed or prevented altogether. This
delay in dialysis initiation would be unacceptable in most
cases of overwhelming metabolic acidosis.
Another problem we encountered was the inability to assay
for urinary thiocyanate which is often used to confirm cyanide
exposure. Hydroxocobalamin is known to cause a reddish
discoloration of the urine which typically resolves within 48 h
[5]. Urinary thiocyanate levels were measured by spectros-
copy and the reddish color of hydroxocobalamin likely
interfered. This interference has been demonstrated with
other chemistry testing [6]. To further support this assump-
tion, repeat urinary thiocyanate levels sent 72 h after the
antidote was infused was able to be completed with a level
detected at 2 μg/ml (normal 0–20 μg/ml). The interfering
substance was no longer present. It is important to give the
antidote despite the possibility that confirmatory urinary
levels will likely be rendered unobtainable. Pre-treatment
blood and urine samples would avoid this minor limitation.
In summary, hydroxocobalamin is an effective antidote for
cyanide poisoning. However, cliniciansmust also be aware of its
effects on hemodialysis machines which could delay the initia-
tion of this vitally important treatment modality in the severely
acidemic patient. Recognizing and communicating this potential
complication to the treating nephrologist can facilitate adjust-
ment of the hemodialysis machine to enable dialysis to occur.
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